Literature DB >> 25595191

Regulation of cell signaling and apoptosis by tumor suppressor WWOX.

Jui-Yen Lo1, Ying-Tsen Chou1, Feng-Jie Lai2, Li-Jin Hsu3.   

Abstract

Human fragile WWOX gene encodes a tumor suppressor WW domain-containing oxidoreductase (named WWOX, FOR, or WOX1). Functional suppression of WWOX prevents apoptotic cell death induced by a variety of stress stimuli, such as tumor necrosis factor, UV radiation, and chemotherapeutic drug treatment. Loss of WWOX gene expression due to gene deletions, loss of heterozygosity, chromosomal translocations, or epigenetic silencing is frequently observed in human malignant cancer cells. Acquisition of chemoresistance in squamous cell carcinoma, osteosarcoma, and breast cancer cells is associated with WWOX deficiency. WWOX protein physically interacts with many signaling molecules and exerts its regulatory effects on gene transcription and protein stability and subcellular localization to control cell survival, proliferation, differentiation, autophagy, and metabolism. In this review, we provide an overview of the recent advances in understanding the molecular mechanisms by which WWOX regulates cellular functions and stress responses. A potential scenario is that activation of WWOX by anticancer drugs is needed to overcome chemoresistance and trigger cancer cell death, suggesting that WWOX can be regarded as a prognostic marker and a candidate molecule for targeted cancer therapies.
© 2015 by the Society for Experimental Biology and Medicine.

Entities:  

Keywords:  Tumor suppressor; apoptosis; chemoresistance; signal transduction; transcription factor

Mesh:

Substances:

Year:  2015        PMID: 25595191      PMCID: PMC4935227          DOI: 10.1177/1535370214566747

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  62 in total

1.  Inhibition of breast cancer cell growth in vitro and in vivo: effect of restoration of Wwox expression.

Authors:  Dimitrios Iliopoulos; Muller Fabbri; Teresa Druck; Haiyan R Qin; Shuang-Yin Han; Kay Huebner
Journal:  Clin Cancer Res       Date:  2007-01-01       Impact factor: 12.531

2.  WW domain-containing oxidoreductase: a candidate tumor suppressor.

Authors:  Nan-Shan Chang; Li-Jin Hsu; Yee-Shin Lin; Feng-Jie Lai; Hamm-Ming Sheu
Journal:  Trends Mol Med       Date:  2006-12-04       Impact factor: 11.951

3.  WWOX: a candidate tumor suppressor gene involved in multiple tumor types.

Authors:  A J Paige; K J Taylor; C Taylor; S G Hillier; S Farrington; D Scott; D J Porteous; J F Smyth; H Gabra; J E Watson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

4.  WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer.

Authors:  A K Bednarek; K J Laflin; R L Daniel; Q Liao; K A Hawkins; C M Aldaz
Journal:  Cancer Res       Date:  2000-04-15       Impact factor: 12.701

5.  17beta-Estradiol upregulates and activates WOX1/WWOXv1 and WOX2/WWOXv2 in vitro: potential role in cancerous progression of breast and prostate to a premetastatic state in vivo.

Authors:  Nan-Shan Chang; Lori Schultz; Li-Jin Hsu; Jennifer Lewis; Meng Su; Chun-I Sze
Journal:  Oncogene       Date:  2005-01-20       Impact factor: 9.867

6.  WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function.

Authors:  Rami I Aqeilan; Valentina Donati; Alexey Palamarchuk; Francesco Trapasso; Mohamed Kaou; Yuri Pekarsky; Marius Sudol; Carlo M Croce
Journal:  Cancer Res       Date:  2005-08-01       Impact factor: 12.701

7.  WWOX binds the specific proline-rich ligand PPXY: identification of candidate interacting proteins.

Authors:  John H Ludes-Meyers; Hyunsuk Kil; Andrzej K Bednarek; Jeff Drake; Mark T Bedford; C Marcelo Aldaz
Journal:  Oncogene       Date:  2004-06-24       Impact factor: 9.867

8.  Association of Wwox with ErbB4 in breast cancer.

Authors:  Rami I Aqeilan; Valentina Donati; Eugenio Gaudio; Milena S Nicoloso; Maria Sundvall; Anna Korhonen; Johan Lundin; Jorma Isola; Marius Sudol; Heikki Joensuu; Carlo M Croce; Klaus Elenius
Journal:  Cancer Res       Date:  2007-10-01       Impact factor: 12.701

9.  Tumor suppressor WWOX binds to ΔNp63α and sensitizes cancer cells to chemotherapy.

Authors:  Z Salah; T Bar-mag; Y Kohn; F Pichiorri; T Palumbo; G Melino; R I Aqeilan
Journal:  Cell Death Dis       Date:  2013-01-31       Impact factor: 8.469

10.  Complement C1q activates tumor suppressor WWOX to induce apoptosis in prostate cancer cells.

Authors:  Qunying Hong; Chun-I Sze; Sing-Ru Lin; Ming-Hui Lee; Ruei-Yu He; Lori Schultz; Jean-Yun Chang; Shean-Jen Chen; Robert J Boackle; Li-Jin Hsu; Nan-Shan Chang
Journal:  PLoS One       Date:  2009-06-01       Impact factor: 3.240

View more
  15 in total

1.  Angiomotin Counteracts the Negative Regulatory Effect of Host WWOX on Viral PPxY-Mediated Egress.

Authors:  Jingjing Liang; Gordon Ruthel; Cari A Sagum; Mark T Bedford; Sachdev S Sidhu; Marius Sudol; Chaitanya K Jaladanki; Hao Fan; Bruce D Freedman; Ronald N Harty
Journal:  J Virol       Date:  2021-02-03       Impact factor: 5.103

2.  WWOX-Mediated Degradation of AMOTp130 Negatively Affects Egress of Filovirus VP40 Virus-Like Particles.

Authors:  Jingjing Liang; Gordon Ruthel; Bruce D Freedman; Ronald N Harty
Journal:  J Virol       Date:  2022-02-02       Impact factor: 6.549

3.  Common genetic variation drives molecular heterogeneity in human iPSCs.

Authors:  Helena Kilpinen; Angela Goncalves; Andreas Leha; Vackar Afzal; Kaur Alasoo; Sofie Ashford; Sendu Bala; Dalila Bensaddek; Francesco Paolo Casale; Oliver J Culley; Petr Danecek; Adam Faulconbridge; Peter W Harrison; Annie Kathuria; Davis McCarthy; Shane A McCarthy; Ruta Meleckyte; Yasin Memari; Nathalie Moens; Filipa Soares; Alice Mann; Ian Streeter; Chukwuma A Agu; Alex Alderton; Rachel Nelson; Sarah Harper; Minal Patel; Alistair White; Sharad R Patel; Laura Clarke; Reena Halai; Christopher M Kirton; Anja Kolb-Kokocinski; Philip Beales; Ewan Birney; Davide Danovi; Angus I Lamond; Willem H Ouwehand; Ludovic Vallier; Fiona M Watt; Richard Durbin; Oliver Stegle; Daniel J Gaffney
Journal:  Nature       Date:  2017-05-10       Impact factor: 49.962

4.  Hyaluronan activates Hyal-2/WWOX/Smad4 signaling and causes bubbling cell death when the signaling complex is overexpressed.

Authors:  Li-Jin Hsu; Qunying Hong; Shur-Tzu Chen; Hsiang-Lin Kuo; Lori Schultz; John Heath; Sing-Ru Lin; Ming-Hui Lee; Dong-Zhang Li; Zih-Ling Li; Hui-Ching Cheng; Gerard Armand; Nan-Shan Chang
Journal:  Oncotarget       Date:  2017-03-21

5.  Functional genetic variant of WW domain-containing oxidoreductase (WWOX) gene is associated with hepatocellular carcinoma risk.

Authors:  Hsiang-Lin Lee; Hsin-Lin Cheng; Yu-Fan Liu; Ming-Chih Chou; Shun-Fa Yang; Ying-Erh Chou
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

6.  Association of WWOX rs9926344 polymorphism with poor prognosis of hepatocellular carcinoma.

Authors:  Wanyong Chen; Chenhao Zhou; Wentao Zhang; Manar Atyah; Yirui Yin; Lei Guo; Weiguo Tang; Qiongzhu Dong; Qinghai Ye; Ning Ren
Journal:  J Cancer       Date:  2018-03-14       Impact factor: 4.207

7.  A meta-analysis of multiple matched aCGH/expression cancer datasets reveals regulatory relationships and pathway enrichment of potential oncogenes.

Authors:  Richard Newton; Lorenz Wernisch
Journal:  PLoS One       Date:  2019-07-23       Impact factor: 3.752

8.  Tumor Suppressor WWOX Contributes to the Elimination of Tumorigenic Cells in Drosophila melanogaster.

Authors:  Louise V O'Keefe; Cheng Shoou Lee; Amanda Choo; Robert I Richards
Journal:  PLoS One       Date:  2015-08-24       Impact factor: 3.240

9.  WWOX CNV-67048 Functions as a Risk Factor for Epithelial Ovarian Cancer in Chinese Women by Negatively Interacting with Oral Contraceptive Use.

Authors:  Yongxiu Chen; Xiaochang Tan; Yongli Ding; Bi Mai; Xiaowen Huang; Guiying Hu; Xiping Luo
Journal:  Biomed Res Int       Date:  2016-04-11       Impact factor: 3.411

10.  Relationship of genetic variant distributions of WW domain-containing oxidoreductase gene with uterine cervical cancer.

Authors:  Yu-Hsiang Lin; Yi-Hsuan Hsiao; Wen-Jun Wu; Shun-Fa Yang; Chun-Fang Hsu; Yu-Ting Kang; Po-Hui Wang
Journal:  Int J Med Sci       Date:  2018-06-14       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.